Publikationen - Universitätsklinikum Giessen und Marburg

Publikationen

2025

Development of heart-sparing VMAT radiotherapy technique incorporating heart substructures for advanced NSCLC patients.

Agolli L, Exeli AK, Schneider U, Ihne-Schubert SM, Lurtz A, Habermehl D. Radiat Oncol. 2025 Mar 14;20(1):40. doi: 10.1186/s13014-025-02597-9.PMID: 40087770 Free PMC article.

Influence of radiotherapy on cardiac implantable devices and leads-a single-institution analysis and critical evaluation of current guidelines.

Warmbrunn J, Straube C, Haase HU, Sinnecker D, Laugwitz KL, Combs SE, Schneider S, Habermehl D. Strahlenther Onkol. 2025 Apr;201(4):463-471. doi: 10.1007/s00066-024-02345-0. Epub 2025 Jan 10.PMID: 39792262 Free PMC article.

RT for the management of locally advanced rectal cancer: Don't throw the baby with the bath water!

Nicosia L, Bonù ML, Angelicone I, Lunardi G, Niespolo RM, Zannetti M, Agolli L, Chiloiro G, Romano A, Jafari F, Aghili M, Ghalehtaki R, Montesi G, De Felice F, De Renzi F, Magli A, Le Guevelou J, Lupattelli M, Minniti G, Gambacorta MA, Habermehl D, Franco P, Arcangeli S, Buglione di Monale E Bastia M, Alongi F, Osti MF. Radiother Oncol. 2025 Apr;205:110772. doi: 10.1016/j.radonc.2025.110772. Epub 2025 Feb 2.PMID: 39904412 No abstract available.

[For Whom, How and to What End - Neoadjuvant Therapy for Rectal Cancer?]

Willis F, Schwandner T, Reichert M, Amati AL, Habermehl D, Schneider M. Zentralbl Chir. 2025 Apr;150(2):140-150. doi: 10.1055/a-2539-5533. Epub 2025 Apr 8.

Optimizing energy consumption in radiotherapy: standard vs. hypo-/ultra-hypofractionation and becoming SMART (specific, measurable, achievable in radiotherapy).

Exeli AK, Lurtz A, Agolli L, Habermehl D. Strahlenther Onkol. 2025 Jun 17. doi: 10.1007/s00066-025-02419-7. Online ahead of print. PMID: 40526130

From radiation beams to digital streams: social media engagement of German radiotherapy facilities

Ouahmane FZ, Exeli AK, Agolli L, Habermehl D. Strahlenther Onkol. 2025 Jul 17. doi: 10.1007/s00066-025-02439-3. Online ahead of print. PMID: 40676272

Defining failure patterns and dynamics in locally advanced pharyngeal and laryngeal SCC following radiotherapy: Real-World Insights in the modern Era! - PubMed

Agolli L, Reinhard L, Langer C, Arens C, Krombach GA, Harth S, Lurtz A, Exeli AK, Gattenlöhner S, Habermehl D. Clin Transl Radiat Oncol. 2025 Aug 7;55:101026. doi: 10.1016/j.ctro.2025.101026. eCollection 2025 Nov. PMID: 40821397 Free PMC article.

2024

Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial.

Hoegen-Saßmannshausen P, Naumann P, Hoffmeister-Wittmann P, Ben Harrabi S, Seidensaal K, Weykamp F, Mielke T, Ellerbrock M, Habermehl D, Springfeld C, Dill MT, Longerich T, Schirmacher P, Mehrabi A, Chang DH, Hörner-Rieber J, Jäkel O, Haberer T, Combs SE, Debus J, Herfarth K, Liermann J.JHEP Rep. 2024 Mar 11;6(6):101063. doi: 10.1016/j.jhepr.2024.101063. eCollection 2024 Jun.PMID: 38737600 Free PMC article.

Outcome of whole brain irradiation with a dose-escalated simultaneous-integrated boost in patients with multiple large and/or diffuse brain metastases: real live data and review of the literature.

Agolli L, Nicosia L, Hilger T, Iancu G, Exeli AK, Eul B, Struffert T, Acker T, Habermehl D. Discov Oncol. 2024 Aug 7;15(1):336. doi: 10.1007/s12672-024-01176-w.PMID: 39110335 Free PMC article.

Bone marrow toxicity in patients with locally advanced cervical cancer undergoing multimodal treatment with VMAT/IMRT: are there dosimetric predictors for toxicity?

Hallqvist D, Kormann C, Pigorsch S, Kiechle M, Combs SE, Habermehl D. Eur J Med Res. 2024 Aug 31;29(1):445. doi: 10.1186/s40001-024-02041-w.PMID: 39217367 Free PMC article.

Very pronounced bowel sparing during radiation therapy for anal carcinoma using a natural spacer (Myoma) - a case report.

Hoeng L, Exeli AK, Krombach GA, Schwandner T, Agolli L, Habermehl D. Radiat Oncol. 2024 Oct 15;19(1):145. doi: 10.1186/s13014-024-02530-6.PMID: 39407281 Free PMC article.

SMILE-stereotactic multiple fraction radiotherapy for non-spine bone metastases: study protocol for a multicenter, open-label phase III randomized controlled trial.

Foerster R, Zwahlen DR, Schroeder C, Windisch P, Halatsch ME, Alfieri A, Meier C, Hemmatazad H, Aebersold DM, Buchali A, Habermehl D, Batifi N.Trials. 2024 Nov 13;25(1):762. doi: 10.1186/s13063-024-08608-6.PMID: 39538259 Free PMC article.

Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: A multicenter retrospective study - ATLANTIS part I.

Nicosia L, Bonù ML, Angelicone I, Lunardi G, Niespolo RM, Zannetti M, Agolli L, Chiloiro G, Romano A, Jafari F, Aghili M, Ghalehtaki R, Montesi G, De Felice F, De Renzi F, Magli A, Le Guevelou J, Lupattelli M, Minniti G, Gambacorta MA, Habermehl D, Franco P, Arcangeli S, Buglione M, Alongi F, Osti MF. Radiother Oncol. 2025 Mar;204:110701. doi: 10.1016/j.radonc.2024.110701. Epub 2024 Dec 25.PMID: 40130646

2023

Correction to: Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO).

Rogers S, Baumert B, Blanck O, Böhmer D, Boström J, Engenhart-Cabillic R, Ermis E, Exner S, Guckenberger M, Habermehl D, Hemmatazad H, Henke G, Lohaus F, Lux S, Mai S, Minasch D, Rezazadeh A, Steffal C, Temming S, Wittig A, Zweifel C, Riesterer O, Combs SE. Strahlenther Onkol. 2023 Jan;199(1):113-114. doi: 10.1007/s00066-022-02021-1.PMID: 36374315 Free article. No abstract available.

The tumor core boost study: A feasibility study of radical dose escalation to the central part of large tumors with an integrated boost in the palliative treatment setting.

Wittenstein O, Krause F, Fischer M, Domschikowski J, Nitsche M, Henkenberens C, Habermehl D, Dunst J. Strahlenther Onkol. 2023 Mar;199(3):258-267. doi: 10.1007/s00066-022-01976-5. Epub 2022 Jul 20.PMID: 35857073 Free PMC article. Clinical Trial.

Dosimetric Parameters After VMAT Adaptive Radiotherapy in Patients With Locally Advanced NSCLC Undergoing 4DCT.

Agolli L, Eroglu Z, Nicosia L, Habermehl D. Anticancer Res. 2023 Dec;43(12):5573-5582. doi: 10.21873/anticanres.16759.PMID: 38030211